Funding for this research was provided by:
Canadian Institutes of Health Research (FDN-143350)
Received: 27 January 2020
Accepted: 13 April 2020
First Online: 21 April 2020
Ethics approval and consent to participate
: The Research Ethics Board of the Research Institute of the McGill University Health Center approved the study. Verbal consent was obtained from all HCW, rather than written consent, due to concerns expressed by HCW at LMIC sites to sign a form during the pilot phase. To obtain consent, all eligible HCW were listed on a roster then approached individually by local research staff at the TAM training days. A standardized script was read aloud, as well as provided in a written format (i.e. on paper at LMIC sites or via email at Canadian sites) outlining the details of the TAM observations. Then, the HCW who agreed to participate in the TAM observations notified their local research staff member (i.e. told them “I agree to participate” in person or replied via email). The roster was updated to indicate those HCW who were eligible and agreed to participate, and final consent was provided by each HCW individually on the morning of their TAM observations. Before beginning the TAM observations, the research staff would ask the HCW, “Do you consent to participate in the TAM observations?” If the HCW agreed, their consent was checked on the roster by the research assistant. No HCW refused to consent to participate in the TAM observations on the scheduled day.
: Not applicable.
: Anete Trajman is a member of the editorial board of the BMC Health Services Research.